Navigation Links
MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research

SAN DIEGO, April 10 /PRNewswire/ -- MedImmune today announced that researchers will present seven abstracts on the company's oncology portfolio programs at the Annual Meeting of the American Association for Cancer Research, exemplifying the company's long-standing commitment to excellence in oncology research.

"Cancer research has long been a core area of focus at MedImmune and we are proud to share data from our increasingly large oncology portfolio at this year's meeting," said Bahija Jallal, Ph.D., vice president of translational science and head, preclinical oncology.

Investigators will present results from four studies of the novel heat shock protein 90 (Hsp90) inhibitor retaspimycin hydrochloride (also known as IPI-504); two studies of antibodies targeting the CD19 antigen, including MEDI-538 (also known as MT103); and one study of monocyte chemotactic protein-1 (MCP-1).
MedImmune research scheduled to be presented includes:

-- IPI-504, a Novel Hsp90 Inhibitor is Effective in EGFR T790M and

non-T790M Gefitinib-Resistant Lung Cancer Cell Lines (Oral

Presentation: Histone Deacetylase and Heat Shock Protein Inhibitors,

abstract 2450) - Joon O. Park, M.D., Monday, April 14 from 11:55 a.m.

- 12:10 p.m. in Room 24A-C.

-- Pharmaceutical Development of IPI-504, an Aqueous Soluble Analog of

17-AAG and Potent Inhibitor of Hsp90 (Educational Session: From

Chemistry to the Clinic: Pathways for Drug Discovery and Development

- Part 4: Chemical Development: Translating a Potent Agent into a

Registered Product) - James R. Porter, Ph.D., Saturday, April 12 from

4:15 - 4:40 p.m. in Ballroom 20D.

-- IPI-504, a Selective Inhibitor of Hsp90, Exhibits Potent Anti-Tumor

Activity Against Metastatic Melanoma Cell Lines that Harbor B-Raf or

N-Ras Mutations (Poster Session: Pharmacology and Pharmacodynamics,

abstract 4764, post

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. MedImmune Announces Seven Key Promotions and New Hires
7. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
8. MedImmune Submits Biologics License Application to FDA for Motavizumab
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. Seneca Valley High School Student Receives Science Award From MedImmune
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
(Date:10/7/2015)... ... October 07, 2015 , ... ... webinar titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations ... free webinar at . This webinar will be given by Professor ...
(Date:10/7/2015)... Menlo Park, CA and Yokahama, Japan (PRWEB) , ... ... ... Sugiyama Lab at RIKEN have entered into a collaborative agreement to develop a ... interactions (DDIs). , Optivia and the Sugiyama Lab will combine their respective ...
(Date:10/6/2015)... ... October 06, 2015 , ... Researchers ... microscope technology that could help surgeons work with a greater degree of accuracy. ... blood flow and cancerous tissue over real images of blood vessels and other ...
(Date:10/6/2015)... , Oct. 6, 2015  The nonprofit ... that natural ingredients manufacturer Teawolf has adopted the ... Adopt-an-Herb Program . HerbMedPro ™ database ... clinical research on guayusa, a caffeine-containing member of ... comprehensive database available on ABC,s website that provides ...
Breaking Biology Technology:
... Networks Corp. has been recognized by Microsoft ... services. , ,The Madison-based IT solutions provider this month ... Midwest to achieve Microsoft's Enterprise Project Management (EPM) specialization. ... expertise in serving businesses that require the tools and ...
... Wis. Higher revenue from its clinical molecular diagnostic products ... a loss for the quarter ending March 31, 2006. , ,Third ... of $4.4 million, or ($0.11) a diluted share, for the first ... net loss of $4.4 million, or ($0.11) a diluted share, for ...
... Wis. Fiserv, which provides software and services ... revenues in 2006 were up 13 percent to $1.1 ... from the $140 million the company made in the ... , ,Fiserve's activities in the first quarter included repurchasing ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... is often compared to a book. However, it is not so ... rather like a cookbook. The cell reads only those recipes which ... genes; ,reading, in the book of the cell means creating RNA ... The cell uses highly complex, sophisticated regulatory mechanisms to ...
... have created mice that can "smell" light, providing a potent ... basis of olfaction. The work, described this week in ... future study of smell and of complex perception systems that ... "It makes intuitive sense to use odors to study ...
... thousand federal, state and local leaders and physical security ... Regional Airport next May 17-19 to observe demonstrations of ... to personnel, equipment and facilities - in combat zones ... and abroad. Military and civilian representatives of ...
Cached Biology News:
... for all types of yeast two-hybrid studies, including complex ... Choice of two bait vectors for maximum ... Triple reporter strain NMY51 ... Complete set of controls: pLexA-p53, pLexA-lamin ...
... Quickly, effectively seals labware. Waterproof, ... protects anhydrous materials. Can be folded ... without rupturing. Stretched lengthwise at 21C ... Yet when tension is removed, film ...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Biology Products: